Irvine Clinical Research
Private Company
Funding information not available
Overview
Irvine Clinical Research is a private, revenue-generating clinical services company focused exclusively on conducting clinical trials for memory loss, Alzheimer's disease, and dementia. It serves as a critical partner for biopharmaceutical sponsors, managing patient recruitment, trial execution, and high-quality care at its dedicated site. The company's strategic positioning in a high-need therapeutic area and its claim of being the largest independent site of its kind on the West Coast provide a solid foundation for its operations. Its business model is built on providing clinical research services to sponsors while offering free, specialized care to participant communities.
Technology Platform
Operational clinical trial execution platform specializing in neurological disorders, including patient recruitment networks, clinical staff expertise, and GCP-compliant site management. Likely utilizes digital health tools for patient management and data capture.
Opportunities
Risk Factors
Competitive Landscape
Competes with other independent clinical research sites, large site networks (e.g., CTI, Parexel's site network), and academic medical centers with memory disorder clinics on the West Coast. Differentiation is based on specialized focus, claimed size/scale, recruitment speed, and quality of site operations.